Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1987;65(6):885–890.

In vivo response of Plasmodium falciparum to chloroquine in pregnant and non-pregnant women in Siaya District, Kenya*

R W Steketee, A D Brandling-Bennett, D C O Kaseje, I K Schwartz, F C Churchill
PMCID: PMC2491082  PMID: 3325186

Abstract

Chemoprophylaxis using chloroquine (CQ) in suppressive doses has been recommended to protect pregnant women in malarious areas from the adverse effects of malaria during pregnancy. In a malaria-endemic area of western Kenya with CQ-resistant Plasmodium falciparum, we determined the prevalence and density of falciparum infection in gravid and nulligravid women and compared the in-vivo parasite response to CQ using two regimens: 25 mg/kg body weight (CQ25) divided over a period of three days (for high-density parasitaemias) and 5 mg/kg body weight (CQ5) weekly for 4 weeks (for low-density parasitaemias). P. falciparum infections were present in 102 (42%) of 244 pregnant women. A greater proportion of primigravidae were parasitaemic (68%) than nulligravidae (50%, P=0.02) or multigravidae (33%, P <10-6). Primigravidae showed a higher geometric mean parasite density. In the CQ25 treatment group, failure to clear parasites by day 7 was more common in primigravidae than nulligravidae (P=0.008) or multigravidae (P=0.15). In the CQ5 treatment group, primigravidae were more likely to show increasing parasite density than nulligravidae or multigravidae.

In this area of Kenya, virtually all women in their first pregnancy are exposed to malaria and are at greatest risk for malaria infection; compared with other women, they show higher parasite densities and are least likely to respond to chloroquine treatment in areas of chloroquine resistance. Malaria control strategies might be targeted to this group of women, but we are pessimistic about the efficacy of weekly CQ5 where there is chloroquine resistance.

Full text

PDF
885

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. MacCormack C. P., Lwihula G. Failure to participate in a malaria chemosuppression programme: North Mara, Tanzania. J Trop Med Hyg. 1983 Jun;86(3):99–107. [PubMed] [Google Scholar]
  2. McGregor I. A., Wilson M. E., Billewicz W. Z. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg. 1983;77(2):232–244. doi: 10.1016/0035-9203(83)90081-0. [DOI] [PubMed] [Google Scholar]
  3. Nguyen-Dinh P. Etudes sur la chimiorésistance de Plasmodium falciparum en Afrique: données actuelles. Ann Soc Belg Med Trop. 1985;65 (Suppl 2):105–113. [PubMed] [Google Scholar]
  4. Patchen L. C., Mount D. L., Schwartz I. K., Churchill F. C. Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1983 Nov 11;278(1):81–89. doi: 10.1016/s0378-4347(00)84758-1. [DOI] [PubMed] [Google Scholar]
  5. Spencer H. C. Drug-resistant malaria--changing patterns mean difficult decisions. Trans R Soc Trop Med Hyg. 1985;79(6):748–758. doi: 10.1016/0035-9203(85)90108-7. [DOI] [PubMed] [Google Scholar]
  6. van Zon A. A., Eling W. M. Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed Parasitol. 1980 Dec;31(4):402–408. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES